Easy Availability of Treatment to Work in Favor of Global Nausea Medicine Market

Market Highlights:
The global Nausea Medicine Market is set to expand at CAGR of 7.2% during the forecast period (2017-2023), rep0orts Market Research Future (MRFR). Nausea is a kind of stomach distress with involuntary urge to vomit due to a number of factors, such as stomach upset or gastric ulcers. Nausea is common among children and pregnant women. Few common indications of nausea are motion sickness, seasickness, medication, and chemotherapy.
Drivers:
There has been an increase in gastrointestinal diseases such as gastroesophageal reflux disease (GERD), and viral gastroenteritis, which are mainly responsible for nausea. This increase is bound to propel the market growth in coming years as well. Moreover, availability of a wide range of treatment for nausea is envisaged to fuel the market growth. Apart from this, changing lifestyle with shift in dietary habits has brought about a positive influence on the market size.
Competitive Analysis:
·         Pfizer
·         GlaxoSmithKline
·         ANI Pharmaceutical
·         Merck & C
·         Sanofi
·         TESAR
·         F. Hoffmann-La Roche Ltd
Restraints:
Although the market is treading on a positive growth path, it will encounter some restraining factors. These are namely high preference for home remedies, particularly in emerging regions. Ingredients like ginger, lemon, garlic and such food items give tough competition to the conventional form of treatment.
However, it is also observed that these home remedies are temporary solutions, without healing completely. Thus, the market for nausea medicine will remain unaffected, as stated by industry experts.
Market Segmentation:
·         The global nausea medicine market is segmented into type, mode of administration, indication and end user.
·         By type, the market is segmented on the basis of antacids, antagonists, anti-anxiety drugs, steroids, cannabinoids and others. Antacids are sub-segmented into serotonin (5-HT3) antagonists, NK-1 antagonists and dopamine antagonists.
·         Based on mode of administration, the market is segmented into intravenous therapy (IVs), tablets and others. The tablets segment is surging at a swift growth rate as nausea tablets are easier to take and are more convenient to consume.
·         By indication, the market is segmented into gastroesophageal reflux disease (GERD), viral gastroenteritis, motion sickness and seasickness, medication, chemotherapy, and others. With increasing number of patients experiencing nausea associated with chemotherapeutic drug use, the segment of chemotherapy-induced nausea is growing at an exceptional rate.
·         Based on end user, the market is segmented into hospitals, clinics, pharmaceutical companies and others.



Regional Analysis
The Americas claims the largest market for nausea medicine on account of rising prevalence of gastrointestinal diseases such as GERD. Also, the prevalence of nausea is increasing among school-going children, further pushing the market growth upward. Prevalence of viral gastroenteritis is growing in the United States (U.S), particularly among the pediatric population. Furthermore, the prevalence of acute gastrointestinal diseases is found to be high in Canada, which has been instrumental in the market expansion in the region as well.
Europe has secured the second largest market for nausea medicine due to the high prevalence of nausea and vomiting among pregnant women, the population of which is increasing consistently in the region. In addition, there is a massive demand for the diagnosis and treatment of nausea, especially among pregnant women which will fuel the market growth in Europe. There is also prevalence of chemotherapy-induced nausea in the region which is increasing steadily. This factor will play a stellar role in increasing the demand for nausea medicine in the region in the foreseeable future.
The APAC market is projected to grow at the fastest rate on the back of changing lifestyle and growing geriatric population. Also, increasing cases of viral gastritis and gastric ulcer in the region has spurred the demand for nausea medicines in the region.
Lastly, the Middle East & Africa have exhibited a steady rise in the market, which can be attributed to rising prevalence of chemotherapy-induced nausea

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote
Read more

Surgical Drapes and Gowns Market is Growing Dynamically at a Speedy CAGR of 4.4% During Forecast 2018-2023

Market Overview: Market Research Future Reports have accumulated study insights and states that the global surgical drapes and gowns market size is expected to expand significantly by the year 2023 as it already held a valuation of USD 2.23 billion in 2017. Now that with the current scenario, it has been observed that the surgical drapes and gowns market is set to proliferate at a CAGR of 4.4% over the forecast period. Surgical Drapes and Gowns Market Share   Held Valuation Up to USD 2.23 Billion in 2017 and Expected to Proliferate in Coming Years Says Global Top Manufacturers A gown and drape have found its immense importance with its usage in the surgical world. These gowns and drapes are useful in reducing the risk of disease. These are supplied by healthcare professionals for minimizing the exposure of transfer of infection while maintaining sterility of spaces. Since its optimum usage in hospitals and clinics globally, it is gaining significant traction in recent time.
Read more

Dental Lasers Market Growth Values, Advanced Share, Demand Overview and Industry Forecast to 2023

Market Overview: The global Dental Lasers Market , as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period ( 2017-2023 ). Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries. These lasers prevent the need for surgical instruments like coherent light beams, coherent light beams, and handpieces. Dental lasers also offer benefits like less contamination, less trauma, and less bleeding and are being accepted across the globe due to their ability like short healing time, lower light exposure, portability, and does not require anesthesia. Competitive Dashboard: ·          Biolase ·          AMD Lasers ·          Convergent Dental ·          Cao Group ·          Fotona D.D ·          Danaher Corporation- Kavo Dental GmbH ·          Millennium Dental Technologies ·          Ivoclar Vivadent AG ·          Syneron Dental Lasers-Syneron Medical Ltd
Read more